March 4, 2021
Grifols publishes its 2020 Integrated Annual Report as part of its commitment to sustainability
- The report provides stakeholders with a comprehensive view of Grifols’ commitment to long-term growth and innovation, robust corporate governance and environment and social responsibility factors, aligned with its efforts to contribute to the Sustainable Development Goals (SDGs)
- The report fully complies with the requirements and recommendations of the Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB) and has been approved by Grifols’ Board of Directors and verified by an independent external auditor
Barcelona, March 4, 2021.- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare leader in the production of plasma-derived medicines with a proven track record of more than 100 years dedicated to enhancing the health and well-being of people worldwide, released the publication of its 2020 Integrated Annual Report, in addition to other corporate sustainability reports: Sustainable Development Goals (SDGs) set by the United Nations, Grifols’ Socio-Economic Impact, Management of Risks and Opportunities Related to Climate Change, and two new publications, one outlining Grifols’ Social Impact and another regarding its Commitment to Our Donors.
The Integrated Annual Report offers an in-depth analysis of Grifols’ solid financial results; its commitment to long-term growth and innovation; robust corporate governance; and dedication to promoting environmental and social factors.
In terms of GDP contribution and job creation, Grifols' activity in 2020 generated an economic impact of EUR 7,500 million and contributed to 140,000 new jobs (direct, indirect and induced) in the United States, Spain, Germany and Ireland.
Using the social return on investment (SROI) methodology, Grifols also completed its first study to measure the social value generated by its 252 U.S.-based plasma centers. Based on this analysis, Grifols’ operations created a EUR 6,200 million impact on donors, patients and local communities, of which approximately 59% corresponds to patients, 30% to donors and the remaining 11% to local communities.
In terms of its human resources, Grifols continued to reinforce its commitment to diversity, employee development, talent promotion, equal opportunities and gender equality. Women make up 60% of the workforce at Grifols, whose adjusted salary gap is below the market average in its countries of operation.
Approved by Grifols' Board of Directors and verified by an independent external auditor, the 2020 Integrated Annual Report fully complies with the requirements and recommendations of the Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB).
Grifols is recognized among the world’s most sustainable companies and listed on the Dow Jones Sustainability Index, Euronext Vigeo, FTSE4Good and Bloomberg Gender Equality Index.
More details are available here in Grifols' 2020 Integrated Annual Report and in the related sustainability reports.